Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 6221 - 500 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Reset ↻

The Ensign Group to Present at the Oppenheimer & Co. Inc. 34th Annual Healthcare Conference

Read more ››

By: GlobeNewswire - 11 Mar 2024

Virbac : Declaration of the number of shares and voting rights 02/2024

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Virbac SA

Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Fortrea, Inc.

Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Fortrea, Inc.

Replay’s cell therapy product company Syena announces first patient dosed in Phase 1/2 study of TCR-NK cell therapy for multiple myeloma

Read more ››

By: GlobeNewswire - 11 Mar 2024

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Pluri Inc.

ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: ASLAN Pharmaceuticals Ltd.

Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Plus Therapeutics, Inc.

XORTX Reprices Warrants Issued in Connection with Previous Private Placements

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: XORTX Therapeutics Inc

Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Nurix Therapeutics, Inc.

Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Psyence Group Inc.

Lexicon Preparing to Resubmit Sotagliflozin NDA for Type 1 Diabetes Following Feedback From FDA

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Lexicon Pharmaceuticals, Inc.

Apellis Appoints Leading Expert Dr. Philip Ferrone as Chief Medical Retina Advisor

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Apellis Pharmaceuticals, Inc.

ProMIS Neurosciences Strengthens Global Intellectual Property Portfolio

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: ProMIS Neurosciences, Inc.

Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Ventyx Biosciences, Inc.

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: FibroGen, Inc.

ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: ADMA Biologics, Inc.

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Conduit Pharmaceuticals Limited

Microbix Unveils Test Controls for Head and Neck Cancer

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Microbix Biosystems Inc.

Eyenovia to Report Fourth Quarter 2023 Results and Provide Business Update on Monday, March 18th

Read more ››

By: GlobeNewswire - 11 Mar 2024

Related companies: Eyenovia, Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

to the top ↑